How to Decide When to Move to a Systemic and Target IL-13 Versus IL-4 in AD
Dr Sarina Elmariah discusses when to recommend systemic therapy in patients with AD and if the therapy should target IL-13 or IL-4.
Date of Last Review: November 25, 2024
Document Number: VV-MED-152757
Are you satisfied with this content?